Marieke E. Doorenspleet, Lowiek M. Hubers, Emma L. Culver, Lucas J. Maillette de Buy Wenniger, Paul L. Klarenbeek, Roger W. Chapman, Frank Baas, Stan F. van de Graaf, Joanne Verheij, Thomas M. van Gulik, Eleanor Barnes, Ulrich Beuers, and Niek de Vries. Immunoglobulin G4+ B‐Cell Receptor Clones Distinguish Immunoglobulin G4‐Related Disease From Primary Sclerosing Cholangitis and Biliary/Pancreatic Malignancies, Hepatology 2016, 64(2), 501 (https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.28568). The above article, published online on 25 March 2016 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief Dr. David Cohen, and Wiley Periodicals LLC. The retraction was requested by the authors because upon re‐analysis, they concluded that the qPCR results reported in the article were incorrect.
. 2022 Jan 7;75(5):1362. doi: 10.1002/hep.32246
Retracted: Immunoglobulin G4+ B‐cell receptor clones distinguish immunoglobulin G4‐related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies
Issue date 2022 May.
© 2022 American Association for the Study of Liver Diseases.
PMCID: PMC9175544 PMID: 34993969
This retracts the article "Immunoglobulin G4+ B‐cell receptor clones distinguish immunoglobulin G 4‐related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies" in volume 64 on page 501.